I presume it is a lack of interest or the basic oils sellers like AGH and BOD falling out of favor, as the market is in favor of those who are trying clinical trials for specialized novel drugs like BOT and IHL?
Dr Sud from CannVaLate has tipped that as his view for Pot Boom 2.0.
That being said, there has got to be some fundamental metric as to what the correct value of a patient truly is, reflected in MC.
Exponential growth for patients is still the same, SaS growth exceptional and CannVaLate still number one distributor.
Thats IMO of course.
Still would love to find out how to calculate the valuation of 1500-2000 patients in MC.
Rebound time, page-569
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.002(8.00%) |
Mkt cap ! $10.94M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.7¢ | 2.5¢ | $45.16K | 1.746M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1010657 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 786608 | 5 |
View Market Depth
| Last trade - 14.32pm 13/09/2024 (20 minute delay) ? |
| AGH (ASX) Chart |